Selected research
Industry Research
Portable Bioimpedance Analyzer Industry Research Report 2026
Market perspective
The global Portable Bioimpedance Analyzer market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Portable Bioimpedance Analyzer is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Portable Bioimpedance Analyzer is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Portable Bioimpedance Analyzer is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Portable Bioimpedance Analyzer include Emtesys, Omron Healthcare USA, AVANUTRI, LAICA International Corporation, Tanita, Diagnosis, Terraillon, Withings and iHealth, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Portable Bioimpedance Analyzer market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Portable Bioimpedance Analyzer Market by Company
Emtesys
Omron Healthcare USA
AVANUTRI
LAICA International Corporation
Tanita
Diagnosis
Terraillon
Withings
iHealth
Microlife
Bodivis
Fitbit
Medeia
InBody
Etekcity
Vitafit
FitTrack Dara
RJL Systems
Portable Bioimpedance Analyzer Segment by Type
Maximum Load Capacity 150kg
Maximum Load Capacity 180kg
Maximum Load Capacity 135kg
Other
Portable Bioimpedance Analyzer Segment by Application
Hospital
Weight Loss Agencies
Family
Other
Portable Bioimpedance Analyzer Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Portable Bioimpedance Analyzer market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Portable Bioimpedance Analyzer and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Portable Bioimpedance Analyzer.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Portable Bioimpedance Analyzer manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Portable Bioimpedance Analyzer by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Portable Bioimpedance Analyzer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Maximum Load Capacity 150kg
- Maximum Load Capacity 180kg
- Maximum Load Capacity 135kg
- Other
Applications
- Hospital
- Weight Loss Agencies
- Family
- Other
Companies covered
- Emtesys
- Omron Healthcare USA
- AVANUTRI
- LAICA International Corporation
- Tanita
- Diagnosis
- Terraillon
- Withings
- iHealth
- Microlife
- Bodivis
- Fitbit
- Medeia
- InBody
- Etekcity
- Vitafit
- FitTrack Dara
- RJL Systems
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Portable Bioimpedance Analyzer Market Size (2021-2032)
- 2.2.2 Global Portable Bioimpedance Analyzer Sales (2021-2032)
- 2.2.3 Global Portable Bioimpedance Analyzer Market Average Price (2021-2032)
- 2.3 Portable Bioimpedance Analyzer by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Maximum Load Capacity 150kg
- 2.3.3 Maximum Load Capacity 180kg
- 2.3.4 Maximum Load Capacity 135kg
- 2.3.5 Other
- 2.4 Portable Bioimpedance Analyzer by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Weight Loss Agencies
- 2.4.4 Family
- 2.4.5 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Portable Bioimpedance Analyzer Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Portable Bioimpedance Analyzer Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Portable Bioimpedance Analyzer Revenue of Manufacturers (2021-2026)
- 3.4 Global Portable Bioimpedance Analyzer Average Price by Manufacturers (2021-2026)
- 3.5 Global Portable Bioimpedance Analyzer Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Portable Bioimpedance Analyzer, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Portable Bioimpedance Analyzer, Product Type & Application
- 3.8 Global Manufacturers of Portable Bioimpedance Analyzer, Established Date
- 3.9 Global Portable Bioimpedance Analyzer Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Emtesys
- 4.1.1 Emtesys Company Information
- 4.1.2 Emtesys Business Overview
- 4.1.3 Emtesys Portable Bioimpedance Analyzer Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Emtesys Portable Bioimpedance Analyzer Product Portfolio
- 4.1.5 Emtesys Recent Developments
- 4.2 Omron Healthcare USA
- 4.2.1 Omron Healthcare USA Company Information
- 4.2.2 Omron Healthcare USA Business Overview
- 4.2.3 Omron Healthcare USA Portable Bioimpedance Analyzer Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Omron Healthcare USA Portable Bioimpedance Analyzer Product Portfolio
- 4.2.5 Omron Healthcare USA Recent Developments
- 4.3 AVANUTRI
- 4.3.1 AVANUTRI Company Information
- 4.3.2 AVANUTRI Business Overview
- 4.3.3 AVANUTRI Portable Bioimpedance Analyzer Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 AVANUTRI Portable Bioimpedance Analyzer Product Portfolio
- 4.3.5 AVANUTRI Recent Developments
- 4.4 LAICA International Corporation
- 4.4.1 LAICA International Corporation Company Information
- 4.4.2 LAICA International Corporation Business Overview
- 4.4.3 LAICA International Corporation Portable Bioimpedance Analyzer Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 LAICA International Corporation Portable Bioimpedance Analyzer Product Portfolio
- 4.4.5 LAICA International Corporation Recent Developments
- 4.5 Tanita
- 4.5.1 Tanita Company Information
- 4.5.2 Tanita Business Overview
- 4.5.3 Tanita Portable Bioimpedance Analyzer Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Tanita Portable Bioimpedance Analyzer Product Portfolio
- 4.5.5 Tanita Recent Developments
- 4.6 Diagnosis
- 4.6.1 Diagnosis Company Information
- 4.6.2 Diagnosis Business Overview
- 4.6.3 Diagnosis Portable Bioimpedance Analyzer Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Diagnosis Portable Bioimpedance Analyzer Product Portfolio
- 4.6.5 Diagnosis Recent Developments
- 4.7 Terraillon
- 4.7.1 Terraillon Company Information
- 4.7.2 Terraillon Business Overview
- 4.7.3 Terraillon Portable Bioimpedance Analyzer Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Terraillon Portable Bioimpedance Analyzer Product Portfolio
- 4.7.5 Terraillon Recent Developments
- 4.8 Withings
- 4.8.1 Withings Company Information
- 4.8.2 Withings Business Overview
- 4.8.3 Withings Portable Bioimpedance Analyzer Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Withings Portable Bioimpedance Analyzer Product Portfolio
- 4.8.5 Withings Recent Developments
- 4.9 iHealth
- 4.9.1 iHealth Company Information
- 4.9.2 iHealth Business Overview
- 4.9.3 iHealth Portable Bioimpedance Analyzer Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 iHealth Portable Bioimpedance Analyzer Product Portfolio
- 4.9.5 iHealth Recent Developments
- 4.10 Microlife
- 4.10.1 Microlife Company Information
- 4.10.2 Microlife Business Overview
- 4.10.3 Microlife Portable Bioimpedance Analyzer Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Microlife Portable Bioimpedance Analyzer Product Portfolio
- 4.10.5 Microlife Recent Developments
- 4.11 Bodivis
- 4.11.1 Bodivis Company Information
- 4.11.2 Bodivis Business Overview
- 4.11.3 Bodivis Portable Bioimpedance Analyzer Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Bodivis Portable Bioimpedance Analyzer Product Portfolio
- 4.11.5 Bodivis Recent Developments
- 4.12 Fitbit
- 4.12.1 Fitbit Company Information
- 4.12.2 Fitbit Business Overview
- 4.12.3 Fitbit Portable Bioimpedance Analyzer Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Fitbit Portable Bioimpedance Analyzer Product Portfolio
- 4.12.5 Fitbit Recent Developments
- 4.13 Medeia
- 4.13.1 Medeia Company Information
- 4.13.2 Medeia Business Overview
- 4.13.3 Medeia Portable Bioimpedance Analyzer Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Medeia Portable Bioimpedance Analyzer Product Portfolio
- 4.13.5 Medeia Recent Developments
- 4.14 InBody
- 4.14.1 InBody Company Information
- 4.14.2 InBody Business Overview
- 4.14.3 InBody Portable Bioimpedance Analyzer Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 InBody Portable Bioimpedance Analyzer Product Portfolio
- 4.14.5 InBody Recent Developments
- 4.15 Etekcity
- 4.15.1 Etekcity Company Information
- 4.15.2 Etekcity Business Overview
- 4.15.3 Etekcity Portable Bioimpedance Analyzer Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Etekcity Portable Bioimpedance Analyzer Product Portfolio
- 4.15.5 Etekcity Recent Developments
- 4.16 Vitafit
- 4.16.1 Vitafit Company Information
- 4.16.2 Vitafit Business Overview
- 4.16.3 Vitafit Portable Bioimpedance Analyzer Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Vitafit Portable Bioimpedance Analyzer Product Portfolio
- 4.16.5 Vitafit Recent Developments
- 4.17 FitTrack Dara
- 4.17.1 FitTrack Dara Company Information
- 4.17.2 FitTrack Dara Business Overview
- 4.17.3 FitTrack Dara Portable Bioimpedance Analyzer Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 FitTrack Dara Portable Bioimpedance Analyzer Product Portfolio
- 4.17.5 FitTrack Dara Recent Developments
- 4.18 RJL Systems
- 4.18.1 RJL Systems Company Information
- 4.18.2 RJL Systems Business Overview
- 4.18.3 RJL Systems Portable Bioimpedance Analyzer Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 RJL Systems Portable Bioimpedance Analyzer Product Portfolio
- 4.18.5 RJL Systems Recent Developments
5 Global Portable Bioimpedance Analyzer Market Scenario by Region
- 5.1 Global Portable Bioimpedance Analyzer Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Portable Bioimpedance Analyzer Sales by Region: 2021-2032
- 5.2.1 Global Portable Bioimpedance Analyzer Sales by Region: 2021-2026
- 5.2.2 Global Portable Bioimpedance Analyzer Sales by Region: 2027-2032
- 5.3 Global Portable Bioimpedance Analyzer Revenue by Region: 2021-2032
- 5.3.1 Global Portable Bioimpedance Analyzer Revenue by Region: 2021-2026
- 5.3.2 Global Portable Bioimpedance Analyzer Revenue by Region: 2027-2032
- 5.4 North America Portable Bioimpedance Analyzer Market Facts & Figures by Country
- 5.4.1 North America Portable Bioimpedance Analyzer Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Portable Bioimpedance Analyzer Sales by Country (2021-2032)
- 5.4.3 North America Portable Bioimpedance Analyzer Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Portable Bioimpedance Analyzer Market Facts & Figures by Country
- 5.5.1 Europe Portable Bioimpedance Analyzer Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Portable Bioimpedance Analyzer Sales by Country (2021-2032)
- 5.5.3 Europe Portable Bioimpedance Analyzer Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Portable Bioimpedance Analyzer Market Facts & Figures by Country
- 5.6.1 Asia Pacific Portable Bioimpedance Analyzer Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Portable Bioimpedance Analyzer Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Portable Bioimpedance Analyzer Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Portable Bioimpedance Analyzer Market Facts & Figures by Country
- 5.7.1 South America Portable Bioimpedance Analyzer Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Portable Bioimpedance Analyzer Sales by Country (2021-2032)
- 5.7.3 South America Portable Bioimpedance Analyzer Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Portable Bioimpedance Analyzer Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Portable Bioimpedance Analyzer Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Portable Bioimpedance Analyzer Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Portable Bioimpedance Analyzer Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Portable Bioimpedance Analyzer Sales by Type (2021-2032)
- 6.1.1 Global Portable Bioimpedance Analyzer Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Portable Bioimpedance Analyzer Sales Market Share by Type (2021-2032)
- 6.2 Global Portable Bioimpedance Analyzer Revenue by Type (2021-2032)
- 6.2.1 Global Portable Bioimpedance Analyzer Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Portable Bioimpedance Analyzer Revenue Market Share by Type (2021-2032)
- 6.3 Global Portable Bioimpedance Analyzer Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Portable Bioimpedance Analyzer Sales by Application (2021-2032)
- 7.1.1 Global Portable Bioimpedance Analyzer Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Portable Bioimpedance Analyzer Sales Market Share by Application (2021-2032)
- 7.2 Global Portable Bioimpedance Analyzer Revenue by Application (2021-2032)
- 7.2.1 Global Portable Bioimpedance Analyzer Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Portable Bioimpedance Analyzer Revenue Market Share by Application (2021-2032)
- 7.3 Global Portable Bioimpedance Analyzer Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Portable Bioimpedance Analyzer Value Chain Analysis
- 8.1.1 Portable Bioimpedance Analyzer Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Portable Bioimpedance Analyzer Production Mode & Process
- 8.2 Portable Bioimpedance Analyzer Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Portable Bioimpedance Analyzer Distributors
- 8.2.3 Portable Bioimpedance Analyzer Customers
9 Global Portable Bioimpedance Analyzer Analyzing Market Dynamics
- 9.1 Portable Bioimpedance Analyzer Industry Trends
- 9.2 Portable Bioimpedance Analyzer Industry Drivers
- 9.3 Portable Bioimpedance Analyzer Industry Opportunities and Challenges
- 9.4 Portable Bioimpedance Analyzer Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst